Patents and Licenses
OptiGen holds the exclusive license for these tests from Cornell Research Foundation, Inc.:
CEA/CH, US Patent No. 7462455; Canadian Patent No. 2,525,799; European Patent No. EP1652937
CSNB US Patent No. 6,201,114 and US Patent No. 6,428,958
prcd-PRA US Patent No. 5,804,388; prcd-PRA Canadian Patent No. CA2306194; prcd-PRA UK Patent No. 2 341 926
prcd-PRA Mutation US Patent No. 7,312,037; Australian, Canadian and European Patents AU2005202704, CA2507927, EP1609876
prcd-PRA LD US Patent No. 7811761; Canadian and European Patents Pending No. 6256346.5
RD/OSD US Patent No. 8,119,343; Australian Patent No. AU2008293550; Canadian Patent Pending CA2698202
Other Exclusive Licenses held by OptiGen:
OptiGen holds the exclusive license for CL testing in the U.S. and a non-exclusive license for other regions from the inventors at U. of New South Wales and the Border Collie Club of NSW, Australia, for this test. US Patent 7,723,034
OptiGen holds the exclusive license for this test from the inventors at the Swedish University in Uppsala, Sweden: CLAD Patent No. 6,210,897
OptiGen holds the exclusive U.S. and Canada license for this test from Merlogen, LLC: FN Patent No. 7,285,388
OptiGen is the exclusive authorized seller in the US of the Antagene test for NCL-A in the American Staffordshire and Pit Bull Terriers US Patent No 845,203
OptiGen is the exclusive authorized seller in the US of the Antagene Ichthyosis test for Golden Retrievers Patent Pending 13/510,620
OptiGen holds an exclusive license for use of patent No US 6140115 A for testing of GM1-Gangliosidosis in the Portuguese Water Dog
Other Licenses held by OptiGen:
OptiGen holds a license from the Animal Health Trust for GR_PRA2 testing in North and South America for Golden Retrievers. Patent Pending PCT/GB2013/051365
OptiGen holds a license from the Animal Health Trust for use of US patent No 8124337 for testing Hereditary Cataracts.
OptiGen tests are provided pursuant to a license from Genetic Technologies Limited for their Non-Coding/Mapping Patents.
Feb.1, 2015 OptiGen tests licensed to Specialist Diagnostic Services/Animal Network in Leichhardt NSW, Australia.